Laboratory Tests for Bilateral Renal Cysts and Hydronephrosis
Order serum creatinine with eGFR calculation, serum cystatin C if eGFR accuracy is uncertain, complete metabolic panel including electrolytes and acid-base status, urinalysis with microscopy, and urine albumin-to-creatinine ratio as your initial laboratory workup 1.
Core Laboratory Panel
The KDIGO 2024 CKD guidelines provide the framework for laboratory evaluation when structural kidney abnormalities are detected 1:
Initial Assessment
- Serum creatinine with eGFR calculation - This is your starting point for assessing kidney function 1
- Serum cystatin C - Add this when eGFR accuracy is questionable or when more precise GFR assessment is needed for clinical decision-making 1
- Complete metabolic panel including:
- Electrolytes (sodium, potassium, chloride, bicarbonate)
- Blood urea nitrogen
- Acid-base status 1
Urine Studies
- Urinalysis with sediment examination - Critical for detecting hematuria or albuminuria, which helps determine differential diagnosis 1
- Urine albumin-to-creatinine ratio - Essential for detecting and quantifying kidney damage 1
Additional Testing Based on Clinical Context
If ADPKD is Suspected
Given bilateral renal cysts, you must consider autosomal dominant polycystic kidney disease (ADPKD). The KDIGO 2025 ADPKD guidelines emphasize that laboratory tests are secondary to imaging and genetic testing for ADPKD diagnosis 2. However, the baseline kidney function tests above remain essential for:
- Establishing baseline renal function
- Monitoring disease progression
- Guiding treatment decisions
Serologic Testing for Other Causes
If clinical features suggest alternative diagnoses beyond simple cysts or ADPKD, consider 1:
- Serum protein electrophoresis with immunofixation and serum-free light chains (if concerned about monoclonal gammopathy of renal significance)
- Anti-PLA2R, ANCA, anti-GBM antibodies (if glomerular disease is suspected based on urinalysis findings)
Critical Pitfalls to Avoid
Don't rely solely on serum creatinine - It can be inaccurate in patients with altered muscle mass, extremes of age, or certain dietary patterns. Use cystatin C for confirmation when eGFR is critical for decision-making 1
Don't skip urinalysis - The presence or absence of hematuria and proteinuria fundamentally changes your differential diagnosis and guides whether additional serologic testing is needed 1
Don't order genetic testing before imaging - For ADPKD diagnosis, imaging (ultrasound or MRI) comes first, with genetic testing reserved for equivocal cases, atypical presentations, or when additional prognostic information is needed 2
Algorithmic Approach
Step 1: Order the core panel (creatinine/eGFR, cystatin C if needed, CMP, urinalysis, urine albumin-to-creatinine ratio)
Step 2: If urinalysis shows persistent hematuria or significant proteinuria → add serologic testing for glomerular diseases 1
Step 3: If bilateral cysts suggest ADPKD → proceed with imaging-based diagnosis per KDIGO 2025 criteria, not additional labs 2
Step 4: If hydronephrosis is severe or bilateral → the laboratory results guide urgency of intervention but imaging determines the anatomic cause
The laboratory evaluation serves to establish baseline kidney function, detect concurrent kidney damage, and monitor progression rather than to diagnose the structural abnormalities themselves, which require imaging 1.